A Phase 2 Study of Galunisertib (TGF-β1 Receptor Type I Inhibitor) and Sorafenib in Patients With Advanced Hepatocellular Carcinoma von Kelley, R K, Gane, E, Assenat, E, Siebler, J, Galle, P R, Merle, P, Hourmand, I O, Cleverly, A, Zhao, Y, Gueorguieva, I, Lahn, M, Faivre, S, Benhadji, K A, Giannelli, G

Volltext

VP10-2021: Cabozantinib (C) plus atezolizumab (A) versus sorafenib (S) as first-line systemic treatment for advanced hepatocellular carcinoma (aHCC): Results from the randomized ph... von Kelley, R.K., Yau, T., Cheng, A.-L., Kaseb, A., Qin, S., Zhu, A.X., Chan, S., Sukeepaisarnjaroen, W., Breder, V., Verset, G., Gane, E., Borbath, I., Gomez Rangel, J.D., Merle, P., Benzaghou, F.M., Banerjee, K., Hazra, S., Fawcett, J., Rimassa, L.

Volltext

Common dysregulation of Wnt Frizzled receptor elements in human hepatocellular carcinoma von Bengochea, A, de Souza, M M, Lefrançois, L, Le Roux, E, Galy, O, Chemin, I, Kim, M, Wands, J R, Trepo, C, Hainaut, P, Scoazec, J-Y, Vitvitski, L, Merle, P

Volltext

DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection von Fan, H, Cui, Z, Zhang, H, Mani, S K, Diab, A, Lefrancois, L, Fares, N, Merle, P, Andrisani, O

Volltext

Radiation therapy of hepatic haemangiomas: Review from a case report von Mesny, E, Mornex, F, Rode, A, Merle, P

Volltext

Marine ecosystems’ responses to climatic and anthropogenic forcings in the Mediterranean von Durrieu de Madron, X, Guieu, C, Sempéré, R, Conan, P, Cossa, D, D’Ortenzio, F, Estournel, C, Gazeau, F, Rabouille, C, Stemmann, L, Bonnet, S, Diaz, F, Koubbi, P, Radakovitch, O, Babin, M, Baklouti, M, Bancon-Montigny, C, Belviso, S, Bensoussan, N, Bonsang, B, Bouloubassi, I, Brunet, C, Cadiou, J.-F, Carlotti, F, Chami, M, Charmasson, S, Charrière, B, Dachs, J, Doxaran, D, Dutay, J.-C, Elbaz-Poulichet, F, Eléaume, M, Eyrolles, F, Fernandez, C, Fowler, S, Francour, P, Gaertner, J.C, Galzin, R, Gasparini, S, Ghiglione, J.-F, Gonzalez, J.-L, Goyet, C, Guidi, L, Guizien, K, Heimbürger, L.-E, Jacquet, S.H.M, Jeffrey, W.H, Joux, F, Le Hir, P, Leblanc, K, Lefèvre, D, Lejeusne, C, Lemé, R, Loÿe-Pilot, M.-D, Mallet, M, Méjanelle, L, Mélin, F, Mellon, C, Mérigot, B, Merle, P.-L, Migon, C, Miller, W.L, Mortier, L, Mostajir, B, Mousseau, L, Moutin, T, Para, J, Pérez, T, Petrenko, A, Poggiale, J.-C, Prieur, L, Pujo-Pay, M, Pulido-Villena, Raimbault, P, Rees, A.P, Ridame, C, Rontani, J.-F, Ruiz Pino, D, Sicre, M.A, Taillandier, V, Tamburini, C, Tanaka, T, Taupier-Letage, I, Tedetti, M, Testor, P, Thébault, H, Thouvenin, B, Touratier, F, Tronczynski, J, Ulses, C, Van Wambeke, F, Vantrepotte, V, Vaz, S, Verney, R

Volltext

Myogenic Disease and Metabolic Acidosis: Consider Multiple Acyl-Coenzyme A Dehydrogenase Deficiency von Brault, C., Maizel, Julien, Sevestre, H., Gourguechon, C., De Lonlay, P., Wicker, C., Acquaviva, Cécile, Bouchereau, J., Dernoncourt, A., Merle, P.-E.

Volltext

HBx triggers either cellular senescence or cell proliferation depending on cellular phenotype von Idrissi, M. E., Hachem, H., Koering, C., Merle, P., Thénoz, M., Mortreux, F., Wattel, E.

Volltext

LBA34 Primary results from the phase III LEAP-002 study: Lenvatinib plus pembrolizumab versus lenvatinib as first-line (1L) therapy for advanced hepatocellular carcinoma (aHCC) von Finn, R.S., Kudo, M., Merle, P., Meyer, T., Qin, S., Ikeda, M., Xu, R., Edeline, J., Ryoo, B-Y., Ren, Z., Cheng, A-L., Galle, P.R., Kaneko, S., Kumada, H., Wang, A., Mody, K., Dubrovsky, L., Siegel, A.B., Llovet, J.

Volltext

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb tri... von Moehler, M., Heo, J., Lee, H.C., Tak, W.Y., Chao, Y., Paik, S.W., Yim, H.J., Byun, K.S., Baron, A., Ungerechts, G., Jonker, D., Ruo, L., Cho, M., Kaubisch, A., Wege, H., Merle, P., Ebert, O., Habersetzer, F., Blanc, J.F., Rosmorduc, Olivier, Lencioni, R., Patt, R., Leen, A.M., Foerster, F., Homerin, M., Stojkowitz, N., Lusky, M., Limacher, J.M., Hennequi, M., Gaspar, N., McFadden, B., De Silva, N., Shen, D., Pelusio, A., Kirn, D.H., Breitbach, C.J., Burke, J.M.

Volltext

Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France von Davion, J.-B., Bocquillon, P., Cassim, F., Frezel, N., Lacour, A., Dhaenens, C.-M., Maurage, C.-A., Gibier, J.-B., Hachulla, E., Nguyen The Tich, S., Defebvre, L., Merle, P.-E., Tard, C.

Volltext

Symbiont diversity is not involved in depth acclimation in the Mediterranean sea whip Eunicella singularis von Forcioli, D, Merle, PL, Caligara, C, Ciosi, M, Muti, C, Francour, P, Cerrano, C, Allemand, D

Volltext

Prevalence of Potentially Inappropriate Medication use in older drivers von Li, Guohua, Andrews, Howard F, Chihuri, Stanford, Lang, Barbara H, Leu, Cheng Shiun, Merle, David P, Gordon, Abigail, Mielenz, Thelma J, Strogatz, David, Eby, David W, Betz, Marian E, DiGuiseppi, Carolyn, Jones, Vanya C, Molnar, Lisa J, Hill, Linda L

Volltext

Osteopontin and latent‐TGF β binding‐protein 2 as potential diagnostic markers for HBV‐related hepatocellular carcinoma von Costa, Andre Nogueira, Plymoth, Amelie, Santos‐Silva, Daniela, Ortiz‐Cuaran, Sandra, Camey, Suzy, Guilloreau, Paule, Sangrajrang, Suleeporn, Khuhaprema, Thiravud, Mendy, Maimuna, Lesi, Olufunmilayo A., Chang, Hee‐Kyung, Oh, Jin‐Kyoung, Lee, Duk‐Hee, Shin, Hai‐Rim, Kirk, Gregory D., Merle, Philippe, Beretta, Laura, Hainaut, Pierre

Volltext

Transarterial chemoembolization followed by moderately hypofractionated radiotherapy in hepatocellular carcinoma: Long-term results of RTF3 regimen von Allignet, B., Merle, P., Rode, A., Mabrut, J.Y., Mohkam, K., Mornex, F.

Volltext

Long-term evaluation of the impact of delivery modalities on anal continence in women with Crohn's disease von Mégier, C., Bourbao-Tournois, C., Perrotin, F., Merle, P., Ouaissi, M., Diguisto, C.

Volltext

A randomized non-comparative phase II study of anti–PD-L1 ATEZOLIZUMAB or chemotherapy as second-line therapy in patients with small cell lung cancer: Results from the IFCT-1603 tr... von Pujol, J.-L., Greillier, L., Audigier Valette, C., Moro-Sibilot, D., Uwer, L., Hureaux, J., Thiberville, L., Carmier, D., Madelaine, J., Otto, J., Gounant, V., Merle, P., Mourlanette, P., Molinier, O., Renault, P.A., Mazieres, J., Antoine, M., Langlais, A., Morin, F., Souquet, P.-J.

Volltext

Screening for precancerous anal lesions linked to human papillomaviruses: French recommendations for clinical practice von Spindler, L., Etienney, I., Abramowitz, L., de Parades, V., Pigot, F., Siproudhis, L., Adam, J., Balzano, V., Bouchard, D., Bouta, N., Bucau, M., Carlo, A., Chanal, J., Charpentier, C., Clifford, G., Draullette, M., Fathallah, N., Ferré, V., Fléjou, J.-F., Fouéré, S., Higuero, T., Kassouri, L., Kurt, S., Laurain, A., Leclerc, E., Lepiller, Q., Lesage, A.-C., Mège, D., Ménard, A., Merle, P., Mortreux, P., Noël, C., Péré, H., Prétet, J.-L., Roland, D., Staumont, G., Tracanelli, L., Vuitton, L., Wylomanski, S., Zaegel-Faucher, O.

Volltext

Ruthenium Grubbs’ catalyst nanostructures grown by UV-excimer-laser ablation for self-healing applications von Aïssa, B., Nechache, R., Haddad, E., Jamroz, W., Merle, P.G., Rosei, F.

Volltext

Gene expression (GE)-based biomarkers associated with nivolumab response in a real-life cohort of patients with metastatic non-small cell lung cancer (mNSCLC) von Radosevic-Robin, N., Ong, S., Warren, S.E., Kossai, M., Godfraind, C., Masson, M., Janicot, H., Merle, P., Dubray-Longueras, P., Durando, X., Morel, P., Cesano, A., Penault-Llorca, F.

Volltext